Randomized clinical study of Gastrografin® administration in patients with adhesive small bowel obstruction

Author:

Biondo S1,Parés D1,Mora L1,Martí Ragué J1,Kreisler E1,Jaurrieta E1

Affiliation:

1. Department of Surgery, Hospital Universitario de Bellvitge, University of Barcelona, Barcelona, Spain

Abstract

Abstract Background Oral Gastrografin® has been used to differentiate partial from complete small bowel obstruction (SBO). It may have a therapeutic effect and predict the need for early surgery in adhesive SBO. The aim of this study was to determine whether contrast examination in the management of SBO allows an early oral intake and reduces hospital stay. Methods Eighty-three patients admitted between February 2000 and November 2001 with 90 episodes of symptoms and signs suggestive of postoperative adhesive SBO were randomized into two groups, a control group and Gastrografin® group. Patients in the control group were treated conservatively. If symptoms of strangulation developed or the obstruction did not resolve spontaneously after 4–5 days, a laparotomy was performed. Patients in the Gastrografin® group received 100 ml Gastrografin®. Those in whom the contrast medium reached the colon in 24 h were considered to have partial SBO, and were fed orally. If Gastrografin® failed to reach the colon and the patient did not improve in the following 24 h a laparotomy was performed. Results Conservative treatment was successful in 77 episodes (85·6 per cent) and 13 (14·4 per cent) required operation. Among patients treated conservatively, hospital stay was shorter in the Gastrografin® group (P < 0·001). All patients in whom contrast medium reached the colon tolerated an early oral diet. Gastrografin® did not reduce the need for operation (P = 1·000). No patient died in either group. Conclusion Oral Gastrografin® helps in the management of patients with adhesive SBO and allows a shorter hospital stay.

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference18 articles.

Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3